Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Genomics|May 1, 1992
Structure of the human TNF receptor 1 (p60) gene (TNFR1) and localization to chromosome 12p13 [corrected]P Fuchs, S Strehl, M Dworzak, et al.
Human Genetics|January 1, 1992
Ewing's tumor X mouse hybrids expressing the MIC2 antigen: analyses using fluorescence CDD-banding and non-isotopic ISHM Dworzak, C Stock, S Strehl, et al.
Leukemia|May 28, 2005
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensityU Creutzig, D Reinhardt, S Diekamp, et al.
Klinische Padiatrie|December 17, 2003
Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000A Attarbaschi, G Mann, M Kronberger, et al.
Pediatric Blood & Cancer|August 31, 2006
Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemiaM Steiner, A Attarbaschi, U Kastner, et al.
Oncogene|July 1, 1990
Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumorH Kovar, M Dworzak, S Strehl, et al.
Onkologie|July 14, 2004
Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemiaD Reinhardt, S Diekamp, G Fleischhack, et al.
Leukemia|June 11, 2010
Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trialsA Sander, M Zimmermann, M Dworzak, et al.
Klinische Padiatrie|August 8, 2002
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study]D Reinhardt, C Langebrake, U Creutzig, et al.
Leukemia|November 21, 2008
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after inductionR Ratei, G Basso, M Dworzak, et al.
Pageof 2